Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03775525
Title Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or Lymphoma (GEN602)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genzada Pharmaceuticals USA, Inc.
Indications

lymphoma

Advanced Solid Tumor

Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.